Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.34 USD | +1.40% | +11.80% | +2.68% |
May. 08 | BofA Securities Starts Sutro Biopharma With Buy Rating | MT |
Apr. 30 | Sutro Biopharma, Inc. Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.68% | 350M | |
+2.59% | 108B | |
+9.74% | 105B | |
+1.57% | 23.46B | |
-12.20% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.46% | 17.19B | |
+6.13% | 13.99B | |
+34.86% | 12.53B |
- Stock Market
- Equities
- STRO Stock
- News Sutro Biopharma, Inc.
- Oppenheimer Initiates Coverage on Sutro Biopharma With Outperform Rating, $10 Price Target